Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes
出版年份 2015 全文链接
标题
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes
作者
关键词
-
出版物
JOURNAL OF INVESTIGATIVE MEDICINE
Volume 63, Issue 2, Pages 267-272
出版商
BMJ
发表日期
2015-10-16
DOI
10.1097/jim.0000000000000129
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
- (2017) Daniel Kopf et al. JOURNAL OF ALZHEIMERS DISEASE
- The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
- (2014) Christian Hölscher Alzheimers & Dementia
- Tau protein kinases: Involvement in Alzheimer's disease
- (2012) Ludovic Martin et al. AGEING RESEARCH REVIEWS
- The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
- (2012) Roger S. McIntyre et al. BEHAVIOURAL BRAIN RESEARCH
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
- (2012) Suzanne M. de la Monte Current Alzheimer Research
- The development of effective biomarkers for Alzheimer's disease: a review
- (2012) Mark S. Henry et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
- (2012) Chong Gao et al. REVIEWS IN THE NEUROSCIENCES
- Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
- (2011) R. Keith Campbell CLINICAL THERAPEUTICS
- Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
- (2011) Nathan Herrmann et al. DRUGS
- A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
- (2011) Sun Ah Park Journal of Clinical Neurology
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test
- (2011) Jonas B. Møller et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Targeting Tau Protein in Alzheimerʼs Disease
- (2010) Cheng-Xin Gong et al. DRUGS & AGING
- Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci
- (2010) Anthony P. Popkie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucagon Like Peptide-1-Directed Human Embryonic Stem Cells Differentiation Into Insulin-Producing Cells Via Hedgehog, cAMP, and PI3K Pathways
- (2010) Hongxiang Hui et al. PANCREAS
- Linking type 2 diabetes and Alzheimer's disease
- (2010) W. Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
- (2009) Talib Abbas et al. BEHAVIOURAL BRAIN RESEARCH
- Brain glucose transporters,O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease
- (2009) Ying Liu et al. JOURNAL OF NEUROCHEMISTRY
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
- (2008) Diana L. Williams et al. ENDOCRINOLOGY
- Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin
- (2008) C.G. Jolivalt et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started